who we are
Years of Experience
0
YOUR TRUSTED PARTNER FROM BIOMARKER DISCOVERY TO CLINICAL ASSAY DEVELOPMENT
At LuminoDx, we are dedicated to pushing the boundaries of precision medicine, leveraging our experience and expertise. We are paving the way in next-gen liquid biopsy analysis from exosome isolation to high content proteomics (O-link), comprehensive molecular testing and clinical assay development. By leveraging the power of liquid biopsy, we aim to increase precision medicines value for therapeutic development and patient treatment.
Services include:
- MOLECULAR-BASED clinical assay development
- EXOSOME-BASED diagnostic biomarker discovery
- Multi-omics analysis of biomarkers in liquid biopsy samples
Patients Received a Liver Transplant
0
+
Olink Publications
0
+
Exosome/EV related publications
0
+
We provide services from biomarker discovery to the commercialization of the test.
Biomarker Discovery
Identification of biomarkers using genomics and proteomics approaches
Assay Development & Qualification
Design, develop, validate high quality assay with an experienced team
Clinical Validation
Design and execute a clinical study to identify and measure the clinical validity and utility
We are Trusted by over 25000+ customers
We are Trusted by over 25000+ customers
We are dedicated to expediting the advancement and market introduction of our proprietary clinical tests, supporting biopharmaceutical companies in achieving faster drug development, and empowering physicians to deliver precise patient care.
Our commitment extends to offering clinical tests through CLIA laboratories or as In Vitro Diagnostic (IVD) products, ensuring the highest quality service to both domestic and global markets.
At LuminoDx, our values are deeply ingrained in our commitment to delivering fast service turnaround times and maintaining the highest standards of quality in all aspects of our work. We prioritize expediting the advancement and market introduction of our proprietary clinical tests, recognizing the urgency in supporting biopharmaceutical companies to accelerate drug development processes. Additionally, we understand the critical importance of empowering physicians with precise diagnostic tools to deliver timely and accurate patient care. Our dedication to excellence extends to offering our clinical tests through research and CLIA laboratories, ensuring rapid delivery without compromising on the quality of our service. Through these values, we aim to make a significant impact on patient outcomes while upholding our commitment to efficiency and excellence in healthcare innovation.